Positives

• Long COVID patients on H1+H2 antihistamine combinations (cetirizine plus famotidine) commonly describe significant improvement in their reactive symptoms, with some saying their flushing, GI distress, and skin reactions resolved within weeks of starting the combination Frontiers in Cardiovascular Medicine.
• Cetirizine has additional mast-cell-stabilizing properties at higher concentrations beyond simple H1 blockade, which may explain why some MCAS-overlap Long COVID patients respond better to it than to other second-generation antihistamines RTHM.
  
  

Negatives

• Some Long COVID patients try cetirizine for several weeks at the standard 10 mg/day dose without seeing any meaningful change in their fatigue, brain fog, or MCAS-like symptoms, and most clinicians say that those non-responders rarely benefit from going up to higher doses either RTHM.
• Cetirizine is more sedating than other second-generation H1 blockers like fexofenadine, and Long COVID patients already struggling with daytime fatigue commonly find the added drowsiness intolerable, especially at the 20-40 mg/day MCAS dose range Drugs.com.

Hurdles & Side Effects

• Standard over-the-counter cetirizine dosing (10 mg/day) is designed for seasonal allergies and is almost always insufficient for MCAS-overlap Long COVID; specialists often titrate up to 20-40 mg/day in divided doses, which can require off-label prescribing and increases sedation risk RTHM.
  
  
• Skin rashes and gastrointestinal symptoms tend to improve first, while fatigue and brain fog improvements (when they occur) typically take weeks to months of consistent dosing Frontiers in Cardiovascular Medicine.